Item Type | Name |
Concept
|
Male
|
Academic Article
|
Long-term effects of antihypertensive regimens on renal hemodynamics and proteinuria.
|
Academic Article
|
Effects of sodium intake on albumin excretion in patients with diabetic nephropathy treated with long-acting calcium antagonists.
|
Academic Article
|
Role of vasopressin in essential hypertension: racial differences.
|
Academic Article
|
Calcium antagonism abolishes the antipressor action of vasopressin (V1) receptor antagonism.
|
Academic Article
|
Effects of dihydropyridine calcium antagonists on albuminuria in patients with diabetes.
|
Academic Article
|
Effect of calcium channel or beta-blockade on the progression of diabetic nephropathy in African Americans.
|
Academic Article
|
Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy.
|
Academic Article
|
Lack of evidence of blood pressure-independent protection by renin-angiotensin system blockade after renal ablation.
|
Academic Article
|
Differential effects of calcium channel blockers on size selectivity of proteinuria in diabetic glomerulopathy.
|
Academic Article
|
ACE inhibition or angiotensin receptor blockade: impact on potassium in renal failure. VAL-K Study Group.
|
Academic Article
|
Combined effects of an angiotensin converting enzyme inhibitor and a calcium antagonist on renal injury.
|
Academic Article
|
Effects of an ACE inhibitor/calcium antagonist combination on proteinuria in diabetic nephropathy.
|
Academic Article
|
The Appropriate Blood Pressure Control in Diabetes (ABCD) Trial.
|
Academic Article
|
Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial.
|
Academic Article
|
Risks for renal involvement in diabetes.
|
Academic Article
|
Renal hemodynamics in radiocontrast medium-induced renal dysfunction: A role for dopamine-1 receptors.
|
Academic Article
|
Antihypertensive efficacy of candesartan in comparison to losartan: the CLAIM study.
|
Academic Article
|
A comparative trial of controlled-onset, extended-release verapamil, enalapril, and losartan on blood pressure and heart rate changes.
|
Academic Article
|
Class differences in the effects of calcium channel blockers in the rat remnant kidney model.
|
Academic Article
|
Implications of a health lifestyle and medication analysis for improving hypertension control.
|
Academic Article
|
Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial.
|
Academic Article
|
Optimal treatment of hypertension in African Americans. Reaching and maintaining target blood pressure goals.
|
Academic Article
|
Impact of an ACE inhibitor and calcium antagonist on microalbuminuria and lipid subfractions in type 2 diabetes: a randomised, multi-centre pilot study.
|
Academic Article
|
Heart failure as a cause for hospitalization in chronic dialysis patients.
|
Academic Article
|
Defining the antihypertensive properties of the angiotensin receptor blocker telmisartan by a practice-based clinical trial.
|
Academic Article
|
Design and statistical aspects of the African American Study of Kidney Disease and Hypertension (AASK).
|
Academic Article
|
Roundtable discussion: problems in the management of hypertension.
|
Academic Article
|
Evaluation and treatment of patients with systemic hypertension.
|
Academic Article
|
Comparison of telmisartan vs. valsartan in the treatment of mild to moderate hypertension using ambulatory blood pressure monitoring.
|
Academic Article
|
Achieving goal blood pressure in patients with type 2 diabetes: conventional versus fixed-dose combination approaches.
|
Academic Article
|
Orlistat improves blood pressure control in obese subjects with treated but inadequately controlled hypertension.
|
Academic Article
|
Quality of life measured in a practice-based hypertension trial of an angiotensin receptor blocker.
|
Academic Article
|
Rosiglitazone reduces urinary albumin excretion in type II diabetes.
|
Academic Article
|
What have we learned from the current trials?
|
Academic Article
|
Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study.
|
Academic Article
|
Comparative effects of selective T- and L-type calcium channel blockers in the remnant kidney model.
|
Academic Article
|
Control of blood pressure and other cardiovascular risk factors at different practice settings: outcomes of care provided to diabetic women compared to men.
|
Academic Article
|
The rationale and design of the AASK cohort study.
|
Academic Article
|
The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: results of the African American study of kidney disease and hypertension.
|
Academic Article
|
beta-Blocker use in long-term dialysis patients: association with hospitalized heart failure and mortality.
|
Academic Article
|
Angiotensin receptor blockade and arterial compliance in chronic kidney disease: a pilot study.
|
Academic Article
|
Differential effects of beta-blockers on albuminuria in patients with type 2 diabetes.
|
Academic Article
|
Rosiglitazone reduces microalbuminuria and blood pressure independently of glycemia in type 2 diabetes patients with microalbuminuria.
|
Academic Article
|
Predictors of development of diabetes mellitus in patients with coronary artery disease taking antihypertensive medications (findings from the INternational VErapamil SR-Trandolapril STudy [INVEST]).
|
Academic Article
|
Validity and reproducibility of HOMA-IR, 1/HOMA-IR, QUICKI and McAuley's indices in patients with hypertension and type II diabetes.
|
Academic Article
|
Antihypertensive agents, insulin sensitivity, and new-onset diabetes.
|
Academic Article
|
Treatment of microalbuminuria in hypertensive subjects with elevated cardiovascular risk: results of the IMPROVE trial.
|
Academic Article
|
Higher prevalence of anemia with diabetes mellitus in moderate kidney insufficiency: The Kidney Early Evaluation Program.
|
Academic Article
|
Effect of fixed-dose ACE-inhibitor/calcium channel blocker combination therapy vs. ACE-inhibitor monotherapy on arterial compliance in hypertensive patients with type 2 diabetes.
|
Academic Article
|
Irbesartan/HCTZ fixed combinations in patients of different racial/ethnic groups with uncontrolled systolic blood pressure on monotherapy.
|
Academic Article
|
Rationale and design of a study to evaluate management of proteinuria in patients at high risk for vascular events: the IMPROVE trial.
|
Academic Article
|
The efficacy and safety of low- and high-dose fixed combinations of irbesartan/hydrochlorothiazide in patients with uncontrolled systolic blood pressure on monotherapy: the INCLUSIVE trial.
|
Academic Article
|
Angiotensin-converting enzyme gene polymorphism predicts the time-course of blood pressure response to angiotensin converting enzyme inhibition in the AASK trial.
|
Academic Article
|
Hypertension control rates: time for translation of guidelines into clinical practice.
|
Academic Article
|
Clinical importance of microalbuminuria in diabetes and hypertension.
|
Academic Article
|
A comparative evaluation of various methods for microalbuminuria screening.
|
Academic Article
|
Race and sex differences in hypertension control in CKD: results from the Kidney Early Evaluation Program (KEEP).
|
Academic Article
|
Efficacy and safety of coadministered amlodipine and atorvastatin in patients with hypertension and dyslipidemia: results of the AVALON trial.
|
Academic Article
|
beta-blocker use and diabetes symptom score: results from the GEMINI study.
|
Academic Article
|
Effects of diltiazem or lisinopril on massive proteinuria associated with diabetes mellitus.
|
Academic Article
|
Effects of theophylline on erythropoietin production in normal subjects and in patients with erythrocytosis after renal transplantation.
|
Academic Article
|
Controlled-release carvedilol in the treatment of essential hypertension.
|
Academic Article
|
Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease.
|
Academic Article
|
Differences in glucose tolerance between fixed-dose antihypertensive drug combinations in people with metabolic syndrome.
|
Academic Article
|
Chronic kidney disease associated mortality in diastolic versus systolic heart failure: a propensity matched study.
|
Academic Article
|
Effects of different calcium antagonists on proteinuria associated with diabetes mellitus.
|
Academic Article
|
Low birth weight is associated with chronic kidney disease only in men.
|
Academic Article
|
Baseline characteristics in the Avoiding Cardiovascular events through Combination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial: a hypertensive population at high cardiovascular risk.
|
Academic Article
|
Lowering blood pressure with beta-blockers in combination with other renin-angiotensin system blockers in patients with hypertension and type 2 diabetes: results from the GEMINI Trial.
|
Academic Article
|
Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.
|
Academic Article
|
Efficacy and safety of fixed combinations of irbesartan/hydrochlorothiazide in older vs younger patients with hypertension uncontrolled with monotherapy.
|
Academic Article
|
Prevalence and associations of anemia of CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004.
|
Academic Article
|
The JNC 7 approach compared to conventional treatment in diabetic patients with hypertension: a double-blind trial of initial monotherapy vs. combination therapy.
|
Academic Article
|
Blood pressure control and improved cardiovascular outcomes in the International Verapamil SR-Trandolapril Study.
|
Academic Article
|
Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients.
|
Academic Article
|
G-protein-coupled receptor kinase 4 polymorphisms and blood pressure response to metoprolol among African Americans: sex-specificity and interactions.
|
Academic Article
|
Chronic kidney disease, prevalence of premature cardiovascular disease, and relationship to short-term mortality.
|
Academic Article
|
Intervention at lower blood pressure levels to achieve target goals in type 2 diabetes: PRADID (PResión Arterial en DIabéticos tipo Dos) study.
|
Academic Article
|
Efficacy and safety of darusentan in patients with resistant hypertension: results from a randomized, double-blind, placebo-controlled dose-ranging study.
|
Academic Article
|
Comparative efficacy of two different beta-blockers on 24-hour blood pressure control.
|
Academic Article
|
The effects of enalapril on urinary protein excretion in patients with idiopathic membranous nephropathy.
|
Academic Article
|
Oxygen free radical involvement in urinary Tamm-Horsfall protein excretion after intrarenal injection of contrast medium.
|
Academic Article
|
The message for World Kidney Day 2009: hypertension and kidney disease: a marriage that should be prevented.
|
Academic Article
|
The rationale and design of the Glycemic Effects in Diabetes Mellitus Carvedilol-Metoprolol Comparison in Hypertensives (GEMINI) trial.
|
Academic Article
|
Rationale and design of a study comparing two fixed-dose combination regimens to reduce albuminuria in patients with type II diabetes and hypertension.
|
Academic Article
|
A propensity-matched study of hypertension and increased stroke-related hospitalization in chronic heart failure.
|
Academic Article
|
Comparison of carvedilol and metoprolol on serum lipid concentration in diabetic hypertensive patients.
|
Academic Article
|
A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial.
|
Academic Article
|
Ambulatory blood pressure monitoring in the primary care setting: assessment of therapy on the circadian variation of blood pressure from the MICCAT-2 Trial.
|
Academic Article
|
The effect of ruboxistaurin on nephropathy in type 2 diabetes.
|
Academic Article
|
Gender disparity in outcomes of care and management for diabetes and the metabolic syndrome.
|
Academic Article
|
Association between hyperuricemia and incident heart failure among older adults: a propensity-matched study.
|
Academic Article
|
Comparative antihypertensive efficacy of angiotensin receptor blocker-based treatment in African-American and white patients.
|
Academic Article
|
Mild hyperkalemia and outcomes in chronic heart failure: a propensity matched study.
|
Academic Article
|
Predictors of hyperkalemia risk following hypertension control with aldosterone blockade.
|
Academic Article
|
Efficacy of a once-daily formulation of carvedilol for the treatment of hypertension.
|
Academic Article
|
CYP3A4 and CYP3A5 polymorphisms and blood pressure response to amlodipine among African-American men and women with early hypertensive renal disease.
|
Academic Article
|
Antihypertensive efficacy of Irbesartan/HCTZ in men and women with the metabolic syndrome and type 2 diabetes.
|
Academic Article
|
Racial differences in kidney function among individuals with obesity and metabolic syndrome: results from the Kidney Early Evaluation Program (KEEP).
|
Academic Article
|
Uncontrolled hypertension and increased risk for incident heart failure in older adults with hypertension: findings from a propensity-matched prospective population study.
|
Academic Article
|
Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial.
|
Academic Article
|
Divergent results using clinic and ambulatory blood pressures: report of a darusentan-resistant hypertension trial.
|
Academic Article
|
Acute interstitial nephritis with glomerulopathy due to nonsteroidal anti-inflammatory agents: a review of its clinical spectrum and effects of steroid therapy.
|
Academic Article
|
The continuum of blood pressure risk: when is the best time to intervene?
|
Academic Article
|
A role for calcium in radiocontrast-induced reductions in renal hemodynamics.
|
Academic Article
|
Cardiovascular events during differing hypertension therapies in patients with diabetes.
|
Academic Article
|
Lower blood pressure goals in high-risk cardiovascular patients: are they defensible?
|
Academic Article
|
Albuminuria and cardiovascular risk.
|
Academic Article
|
Cardiovascular risk modification in participants with coronary disease screened by the Kidney Early Evaluation Program.
|
Academic Article
|
Independent components of chronic kidney disease as a cardiovascular risk state: results from the Kidney Early Evaluation Program (KEEP).
|
Academic Article
|
Amlodipine and valsartan combined and as monotherapy in stage 2, elderly, and black hypertensive patients: subgroup analyses of 2 randomized, placebo-controlled studies.
|
Academic Article
|
Effects of the angiotensin receptor blocker azilsartan medoxomil versus olmesartan and valsartan on ambulatory and clinic blood pressure in patients with stages 1 and 2 hypertension.
|
Academic Article
|
Effect of combining extended-release carvedilol and lisinopril in hypertension: results of the COSMOS study.
|
Academic Article
|
Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) study equations: risk factors for and complications of CKD and mortality in the Kidney Early Evaluation Program (KEEP).
|
Academic Article
|
Importance of blood pressure control in left ventricular mass regression.
|
Academic Article
|
Telmisartan is more effective than losartan in reducing proteinuria in patients with diabetic nephropathy.
|
Academic Article
|
A propensity-matched study of low serum potassium and mortality in older adults with chronic heart failure.
|
Academic Article
|
Hypertension in early-stage kidney disease: an update from the Kidney Early Evaluation Program (KEEP).
|
Academic Article
|
Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP).
|
Academic Article
|
Limitations of metformin use in patients with kidney disease: are they warranted?
|
Academic Article
|
Comparison of the novel angiotensin II receptor blocker azilsartan medoxomil vs valsartan by ambulatory blood pressure monitoring.
|
Academic Article
|
Comparison of measured GFR, serum creatinine, cystatin C, and beta-trace protein to predict ESRD in African Americans with hypertensive CKD.
|
Academic Article
|
Isolated diastolic hypotension and incident heart failure in older adults.
|
Academic Article
|
Dual therapy in hypertensive patients with coronary artery disease: the role of calcium channel blockers and beta-blockers.
|
Academic Article
|
Chronic kidney disease: a coronary heart disease equivalent?
|
Academic Article
|
Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled rheos pivotal trial.
|
Academic Article
|
EXamination of cArdiovascular outcoMes with alogliptIN versus standard of carE in patients with type 2 diabetes mellitus and acute coronary syndrome (EXAMINE): a cardiovascular safety study of the dipeptidyl peptidase 4 inhibitor alogliptin in patients with type 2 diabetes with acute coronary syndrome.
|
Academic Article
|
Baroreflex activation therapy provides durable benefit in patients with resistant hypertension: results of long-term follow-up in the Rheos Pivotal Trial.
|
Academic Article
|
Single-pill combination of telmisartan/amlodipine versus amlodipine monotherapy in diabetic hypertensive patients: an 8-week randomized, parallel-group, double-blind trial.
|
Academic Article
|
Effects of combining simvastatin with rosiglitazone on inflammation, oxidant stress and ambulatory blood pressure in patients with the metabolic syndrome: the SIROCO study.
|
Academic Article
|
Can ambulatory blood pressure serve as a biomarker for presence of chronic kidney disease?
|
Academic Article
|
N-terminal prohormone brain natriuretic peptide as a predictor of cardiovascular disease and mortality in blacks with hypertensive kidney disease: the African American Study of Kidney Disease and Hypertension (AASK).
|
Academic Article
|
Hypokalemia and outcomes in patients with chronic heart failure and chronic kidney disease: findings from propensity-matched studies.
|
Academic Article
|
The renal, forearm, and hormonal responses to standing in the presence and absence of propranolol.
|
Academic Article
|
Predictors of systolic BP <140 mmHg and systolic BP level by randomly assigned treatment group (benazepril plus amlodipine or hydrochlorothiazide) in the ACCOMPLISH Study.
|
Academic Article
|
The diabetes subgroup baseline characteristics of the Avoiding Cardiovascular Events Through Combination Therapy in Patients Living With Systolic Hypertension (ACCOMPLISH) trial.
|
Academic Article
|
Association of NEDD4L ubiquitin ligase with essential hypertension.
|
Academic Article
|
The message for World Kidney Day 2009: hypertension and kidney disease: a marriage that should be prevented.
|
Academic Article
|
Dysglycemia predicts cardiovascular and kidney disease in the Kidney Early Evaluation Program.
|
Academic Article
|
Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease.
|
Academic Article
|
Predictors of hypertension control in a diverse general cardiology practice.
|
Academic Article
|
An effectiveness study comparing algorithm-based antihypertensive therapy with previous treatments using conventional and ambulatory blood pressure measurements.
|
Academic Article
|
Blood pressure-lowering efficacy of the fixed-dose combination of azilsartan medoxomil and chlorthalidone: a factorial study.
|
Academic Article
|
Renal effects of oral prostaglandin supplementation after ibuprofen in diabetic subjects: a double-blind, placebo-controlled, multicenter trial.
|
Academic Article
|
Lithium prophylaxis and the kidney.
|
Academic Article
|
Psychogenic vertigo: a review.
|
Academic Article
|
Using an established telehealth model to train urban primary care providers on hypertension management.
|
Academic Article
|
Dermatologic manifestations of lithium: a review.
|
Academic Article
|
Awareness of kidney disease and relationship to end-stage renal disease and mortality.
|
Academic Article
|
Antihypertensive efficacy of hydrochlorothiazide vs chlorthalidone combined with azilsartan medoxomil.
|
Academic Article
|
ACE inhibitor mediated reductions in renal size and microalbuminuria in normotensive, diabetic subjects.
|
Academic Article
|
Treatment of arterial hypertension in diabetic humans: importance of therapeutic selection.
|
Academic Article
|
Disopyramide-associated liver dysfunction.
|
Academic Article
|
Differential effect of beta-blocker therapy on insulin resistance as a function of insulin sensitizer use: results from GEMINI.
|
Academic Article
|
The use of clonidine for management of opiate abstinence in a chronic pain patient.
|
Academic Article
|
Body weight changes with beta-blocker use: results from GEMINI.
|
Academic Article
|
Radiocontrast medium-induced declines in renal function: a role for oxygen free radicals.
|
Academic Article
|
Reversal of diuretic-associated impaired glucose tolerance and new-onset diabetes: results of the STAR-LET study.
|
Academic Article
|
Effects of different ACE inhibitor combinations on albuminuria: results of the GUARD study.
|
Academic Article
|
Demographic analyses of the effects of carvedilol vs metoprolol on glycemic control and insulin sensitivity in patients with type 2 diabetes and hypertension in the Glycemic Effects in Diabetes Mellitus: Carvedilol-Metoprolol Comparison in Hypertensives (GEMINI) study.
|
Academic Article
|
Risk of hyperkalemia in nondiabetic patients with chronic kidney disease receiving antihypertensive therapy.
|
Academic Article
|
Prevalence of CKD and comorbid illness in elderly patients in the United States: results from the Kidney Early Evaluation Program (KEEP).
|
Academic Article
|
Intensive blood-pressure control in hypertensive chronic kidney disease.
|
Academic Article
|
Malnutrition-inflammation modifies the relationship of cholesterol with cardiovascular disease.
|
Academic Article
|
Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) study equations: prevalence of and risk factors for diabetes mellitus in CKD in the Kidney Early Evaluation Program (KEEP).
|
Academic Article
|
A reappraisal of renin-angiotensin system blockade on microalbuminuria development: do they offer anything unique?
|
Academic Article
|
Renal outcomes in hypertensive Black patients at high cardiovascular risk.
|
Academic Article
|
Blood pressure components and end-stage renal disease in persons with chronic kidney disease: the Kidney Early Evaluation Program (KEEP).
|
Academic Article
|
Role for intrarenal adenosine in the renal hemodynamic response to contrast media.
|
Academic Article
|
Pulmonary scar carcinoma. A clinicopathologic analysis.
|
Academic Article
|
Antihypertensive treatment with and without benazepril in patients with chronic renal insufficiency: a US economic evaluation.
|
Academic Article
|
Hypertension-related disease in African Americans. Factors underlying disparities in illness and its outcome.
|
Academic Article
|
A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
|
Academic Article
|
Effects of COX inhibition on blood pressure and kidney function in ACE inhibitor-treated blacks and hispanics.
|
Academic Article
|
Amlodipine/benazepril combination therapy for hypertensive patients nonresponsive to benazepril monotherapy.
|
Academic Article
|
Clinical outcomes in the diabetes cohort of the INternational VErapamil SR-Trandolapril study.
|
Academic Article
|
Measuring the efficacy of antihypertensive therapy by ambulatory blood pressure monitoring in the primary care setting.
|
Academic Article
|
Atlas vertebra realignment and achievement of arterial pressure goal in hypertensive patients: a pilot study.
|
Academic Article
|
Insulin resistance, hyperinsulinemia, and hypertension: an epidemiologic approach.
|
Academic Article
|
Hypertension awareness, treatment, and control in chronic kidney disease.
|
Academic Article
|
Predictors of blood pressure response to intensified and fixed combination treatment of hypertension: the ACCOMPLISH study.
|
Academic Article
|
Serum potassium and clinical outcomes in the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS).
|
Academic Article
|
Oral potassium supplement use and outcomes in chronic heart failure: a propensity-matched study.
|
Academic Article
|
Obesity is associated with increased parathyroid hormone levels independent of glomerular filtration rate in chronic kidney disease.
|
Academic Article
|
Kidney early evaluation program: a community-based screening approach to address disparities in chronic kidney disease.
|
Academic Article
|
Pediatrics: Masked hypertension: a risk factor in children with CKD.
|
Academic Article
|
Initial assessment, surveillance, and management of blood pressure in patients receiving vascular endothelial growth factor signaling pathway inhibitors.
|
Academic Article
|
Efficacy and duration of benazepril plus amlodipine or hydrochlorothiazide on 24-hour ambulatory systolic blood pressure control.
|
Academic Article
|
The comparative effects of azilsartan medoxomil and olmesartan on ambulatory and clinic blood pressure.
|
Academic Article
|
Effects of naproxcinod on blood pressure in patients with osteoarthritis.
|
Academic Article
|
Renin-angiotensin inhibition in systolic heart failure and chronic kidney disease.
|
Academic Article
|
Azilsartan medoxomil plus chlorthalidone reduces blood pressure more effectively than olmesartan plus hydrochlorothiazide in stage 2 systolic hypertension.
|
Academic Article
|
Comparison of the effects of dopamine and fenoldopam, a selective dopamine-1 agonist, on parathyroid hormone release in man.
|
Academic Article
|
Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease.
|
Academic Article
|
Effects of body size and hypertension treatments on cardiovascular event rates: subanalysis of the ACCOMPLISH randomised controlled trial.
|
Academic Article
|
A trial of 2 strategies to reduce nocturnal blood pressure in blacks with chronic kidney disease.
|
Academic Article
|
Obesity, blood pressure, and cardiovascular outcomes - Authors' reply.
|
Academic Article
|
Effects of nebivolol on aortic compliance in patients with diabetes and maximal renin angiotensin system blockade: the EFFORT study.
|
Academic Article
|
Resistant hypertension: a frequent and ominous finding among hypertensive patients with atherothrombosis.
|
Academic Article
|
Association of race and body mass index with ESRD and mortality in CKD stages 3-4: results from the Kidney Early Evaluation Program (KEEP).
|
Academic Article
|
Systolic blood pressure and cardiovascular outcomes during treatment of hypertension.
|
Academic Article
|
Comparison of benazepril plus amlodipine or hydrochlorothiazide in high-risk patients with hypertension and coronary artery disease.
|
Academic Article
|
The author replies.
|
Academic Article
|
The OSCAR for cardiovascular disease prevention in chronic kidney disease goes to blood pressure control.
|
Academic Article
|
Antihypertensive efficacy of the angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril.
|
Academic Article
|
Randomized study of antihypertensive efficacy and safety of combination aliskiren/valsartan vs valsartan monotherapy in hypertensive participants with type 2 diabetes mellitus.
|
Academic Article
|
Initial single-pill combination therapy for cardiovascular risk factor management: it is not just convenience.
|
Academic Article
|
Risk factors for heart failure in patients with type 2 diabetes mellitus and stage 4 chronic kidney disease treated with bardoxolone methyl.
|
Academic Article
|
Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes mellitus and chronic kidney disease.
|
Academic Article
|
Evidence-based triple antihypertensive therapy yields lower mortality in older patients with diabetes mellitus.
|
Academic Article
|
Renal denervation and left ventricular mass regression: a benefit beyond blood pressure reduction?
|
Academic Article
|
Efficacy and safety of canagliflozin in patients with type 2 diabetes and stage 3 nephropathy.
|
Academic Article
|
Renal denervation for resistant hypertension.
|
Academic Article
|
A controlled trial of renal denervation for resistant hypertension.
|
Academic Article
|
Sorafenib dose escalation is not uniformly associated with blood pressure elevations in normotensive patients with advanced malignancies.
|
Academic Article
|
Orthostatic hypotension associated with baroreceptor dysfunction: treatment approaches.
|
Academic Article
|
Mechanisms contributing to adverse cardiovascular events in patients with type 2 diabetes mellitus and stage 4 chronic kidney disease treated with bardoxolone methyl.
|
Academic Article
|
Impact of renal denervation on 24-hour ambulatory blood pressure: results from SYMPLICITY HTN-3.
|
Academic Article
|
Renin inhibition in patients with chronic kidney disease: is it conclusively non-indicated?
|
Academic Article
|
Association of cognitive dysfunction with cardiovascular disease events in elderly hypertensive patients.
|
Academic Article
|
Predictors and outcomes of resistant hypertension among patients with coronary artery disease and hypertension.
|
Academic Article
|
Dynamic resistant hypertension patterns as predictors of cardiovascular morbidity: a 4-year prospective study.
|
Academic Article
|
Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease.
|
Academic Article
|
Effects of antihypertensive treatment in Asian populations: a meta-analysis of prospective randomized controlled studies (CARdiovascular protectioN group in Asia: CARNA).
|
Academic Article
|
Effect of aliskiren on progression of coronary disease in patients with prehypertension: the AQUARIUS randomized clinical trial.
|
Academic Article
|
Alogliptin after acute coronary syndrome in patients with type 2 diabetes.
|
Academic Article
|
Both chronic kidney disease and nocturnal blood pressure associate with strokes in the elderly.
|
Academic Article
|
Determinants and changes associated with aldosterone breakthrough after angiotensin II receptor blockade in patients with type 2 diabetes with overt nephropathy.
|
Academic Article
|
Early patterns of blood pressure change and future coronary atherosclerosis.
|
Academic Article
|
Baseline characteristics in the Bardoxolone methyl EvAluation in patients with Chronic kidney disease and type 2 diabetes mellitus: the Occurrence of renal eveNts (BEACON) trial.
|
Academic Article
|
In search for the 'sweet spot' for blood pressure level in diabetes.
|
Academic Article
|
Effects of combining azilsartan medoxomil with amlodipine in patients with stage 2 hypertension.
|
Academic Article
|
Evaluating the role of key learning theories in ECHO: a telehealth educational program for primary care providers.
|
Academic Article
|
Rationale, design, and baseline characteristics of ARTS-DN: a randomized study to assess the safety and efficacy of finerenone in patients with type 2 diabetes mellitus and a clinical diagnosis of diabetic nephropathy.
|
Academic Article
|
Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors.
|
Academic Article
|
Predictors of blood pressure response in the SYMPLICITY HTN-3 trial.
|
Academic Article
|
Efficacy and safety of perindopril arginine + amlodipine in hypertension.
|
Academic Article
|
New agents for hyperkalemia.
|
Academic Article
|
Incidence, determinants, and prognostic significance of hyperkalemia and worsening renal function in patients with heart failure receiving the mineralocorticoid receptor antagonist eplerenone or placebo in addition to optimal medical therapy: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF).
|
Academic Article
|
Reply: A mechanistic explanation for the minimal impact of renal denervation on 24-h ambulatory blood pressure in SIMPLICITY HTN-3.
|
Academic Article
|
Racial impact of diurnal variations in blood pressure on cardiovascular events in chronic kidney disease.
|
Academic Article
|
12-month blood pressure results of catheter-based renal artery denervation for resistant hypertension: the SYMPLICITY HTN-3 trial.
|
Academic Article
|
Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial.
|
Academic Article
|
Resting heart rate is associated with renal disease outcomes in patients with vascular disease: results of the ONTARGET and TRANSCEND studies.
|
Academic Article
|
Renal Denervation After SYMPLICITY HTN-3: Where Do We Go?
|
Academic Article
|
Effect of Patiromer on Serum Potassium Level in Patients With Hyperkalemia and Diabetic Kidney Disease: The AMETHYST-DN Randomized Clinical Trial.
|
Academic Article
|
Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy: A Randomized Clinical Trial.
|
Academic Article
|
An analysis of the blood pressure and safety outcomes to renal denervation in African Americans and Non-African Americans in the SYMPLICITY HTN-3 trial.
|
Academic Article
|
Effect of patiromer on reducing serum potassium and preventing recurrent hyperkalaemia in patients with heart failure and chronic kidney disease on RAAS inhibitors.
|
Academic Article
|
Correlations of plasma renin activity and aldosterone concentration with ambulatory blood pressure responses to nebivolol and valsartan, alone and in combination, in hypertension.
|
Academic Article
|
Effect of Catheter-Based Renal Denervation on Morning and Nocturnal Blood Pressure: Insights From SYMPLICITY HTN-3 and SYMPLICITY HTN-Japan.
|
Academic Article
|
Effects of aliskiren in diabetic and non-diabetic patients with coronary artery disease: Insights from AQUARIUS.
|
Academic Article
|
Spironolactone for resistant hypertension--hard to resist?
|
Academic Article
|
Finerenone for Albuminuria in Patients With Diabetic Nephropathy--Reply.
|
Academic Article
|
Effects of azilsartan medoxomil compared with olmesartan and valsartan on ambulatory and clinic blood pressure in patients with type 2 diabetes and prediabetes.
|
Academic Article
|
Effect of Naltrexone-Bupropion on Major Adverse Cardiovascular Events in Overweight and Obese Patients With Cardiovascular Risk Factors: A Randomized Clinical Trial.
|
Academic Article
|
Hydrochlorothiazide as the Diuretic of Choice for Hypertension: Time to Kick the Habit.
|
Academic Article
|
Cardiovascular Outcomes According to Systolic Blood Pressure in Patients With and Without Diabetes: An ACCOMPLISH Substudy.
|
Academic Article
|
Ischemic cardiac outcomes and hospitalizations according to prior macrovascular disease status in patients with type 2 diabetes and recent acute coronary syndrome from the Examination of Cardiovascular Outcomes with Alogliptin versus Standard of Care trial.
|
Academic Article
|
Impact of Renal Denervation on Patients With Obstructive Sleep Apnea and Resistant Hypertension - Insights From the SYMPLICITY HTN-3 Trial.
|
Academic Article
|
Cardiovascular Mortality in Patients With Type 2 Diabetes and Recent Acute Coronary Syndromes From the EXAMINE Trial.
|
Academic Article
|
Angiotensin-Converting Enzyme Inhibitor Use and Major Cardiovascular Outcomes in Type 2 Diabetes Mellitus Treated With the Dipeptidyl Peptidase 4 Inhibitor Alogliptin.
|
Academic Article
|
Treatment with patiromer decreases aldosterone in patients with chronic kidney disease and hyperkalemia on renin-angiotensin system inhibitors.
|
Academic Article
|
Massachusetts Healthcare Reform and Trends in Emergent Colon Resection.
|
Academic Article
|
Massachusetts Healthcare Reform and Trends in Emergent Colon Resection.
|
Academic Article
|
Effect of Sitagliptin on Kidney Function and Respective Cardiovascular Outcomes in Type 2 Diabetes: Outcomes From TECOS.
|
Academic Article
|
Massachusetts Healthcare Reform and Trends in Emergent Colon Resection.
|
Academic Article
|
Massachusetts Healthcare Reform and Trends in Emergent Colon Resection.
|
Academic Article
|
BP Control and Long-Term Risk of ESRD and Mortality.
|
Academic Article
|
Impact of eplerenone on cardiovascular outcomes in heart failure patients with hypokalaemia.
|
Academic Article
|
Relationship of glycated haemoglobin and reported hypoglycaemia to cardiovascular outcomes in patients with type 2 diabetes and recent acute coronary syndrome events: The EXAMINE trial.
|
Academic Article
|
On-Treatment Blood Pressure and Cardiovascular Outcomes in Older Adults With Isolated Systolic Hypertension.
|
Academic Article
|
An exploratory propensity score matched comparison of second-generation and first-generation baroreflex activation therapy systems.
|
Academic Article
|
Reduced blood pressure-lowering effect of catheter-based renal denervation in patients with isolated systolic hypertension: data from SYMPLICITY HTN-3 and the Global SYMPLICITY Registry.
|
Academic Article
|
Serial Measurement of High-Sensitivity Troponin I and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus in the EXAMINE Trial (Examination of Cardiovascular Outcomes With Alogliptin Versus Standard of Care).
|
Academic Article
|
Sustained Reduction of Blood Pressure With Baroreceptor Activation Therapy: Results of the 6-Year Open Follow-Up.
|
Academic Article
|
Evaluation of the angiotensin II receptor blocker azilsartan medoxomil in African-American patients with hypertension.
|
Academic Article
|
Acute Declines in Renal Function during Intensive BP Lowering: Implications for Future ESRD Risk.
|
Academic Article
|
Prior Medications and the Cardiovascular Benefits From Combination Angiotensin-Converting Enzyme Inhibition Plus Calcium Channel Blockade Among High-Risk Hypertensive Patients.
|
Academic Article
|
Baseline characteristics and enrichment results from the SONAR trial.
|
Academic Article
|
A randomized titrate-to-target study comparing fixed-dose combinations of azilsartan medoxomil and chlorthalidone with olmesartan and hydrochlorothiazide in stage-2 systolic hypertension.
|
Academic Article
|
Rationale and protocol of the Study Of diabetic Nephropathy with AtRasentan (SONAR) trial: A clinical trial design novel to diabetic nephropathy.
|
Academic Article
|
High-sensitivity C-reactive protein, low-density lipoprotein cholesterol and cardiovascular outcomes in patients with type 2 diabetes in the EXAMINE (Examination of Cardiovascular Outcomes with Alogliptin versus Standard of Care) trial.
|
Academic Article
|
Early and Chronic Dipeptidyl-Peptidase-IV Inhibition and Cardiovascular Events in Patients With Type 2 Diabetes Mellitus After an Acute Coronary Syndrome: A Landmark Analysis of the EXAMINE Trial.
|
Academic Article
|
Bardoxolone Methyl Improves Kidney Function in Patients with Chronic Kidney Disease Stage 4 and Type 2 Diabetes: Post-Hoc Analyses from Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes Study.
|
Academic Article
|
Relation of Serum and Urine Renal Biomarkers to Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus and Recent Acute Coronary Syndromes (From the EXAMINE Trial).
|
Academic Article
|
Effect of Patiromer on Hyperkalemia Recurrence in Older Chronic Kidney Disease Patients Taking RAAS Inhibitors.
|
Academic Article
|
Differences in Dynamic Diurnal Blood Pressure Variability Between Japanese and American Treatment-Resistant Hypertensive Populations.
|
Academic Article
|
Long-term efficacy and tolerability of azilsartan medoxomil/chlorthalidone vs olmesartan medoxomil/hydrochlorothiazide in chronic kidney disease.
|
Academic Article
|
The association of interdialytic blood pressure variability with cardiovascular events and all-cause mortality in haemodialysis patients.
|
Academic Article
|
Comparison of Effectiveness of Azilsartan Medoxomil and Olmesartan in Blacks Versus Whites With Systemic Hypertension.
|
Academic Article
|
High screen failure rate in patients with resistant hypertension: Findings from SYMPLICITY HTN-3.
|
Academic Article
|
Cardiovascular and Renal Outcomes With Canagliflozin According to Baseline Kidney Function.
|
Academic Article
|
Hyperuricemia, Acute and Chronic Kidney Disease, Hypertension, and Cardiovascular Disease: Report of a Scientific Workshop Organized by the National Kidney Foundation.
|
Academic Article
|
Kidney Biomarkers and Decline in eGFR in Patients with Type 2 Diabetes.
|
Academic Article
|
Average Clinician-Measured Blood Pressures and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Ischemic Heart Disease in the EXAMINE Trial.
|
Academic Article
|
Efficacy of a novel inhibitor of vascular adhesion protein-1 in reducing albuminuria in patients with diabetic kidney disease (ALBUM): a randomised, placebo-controlled, phase 2 trial.
|
Academic Article
|
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.
|
Academic Article
|
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial.
|
Academic Article
|
Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups.
|
Academic Article
|
Design and Baseline Characteristics of the Finerenone in Reducing Cardiovascular Mortality and Morbidity in Diabetic Kidney Disease Trial.
|
Academic Article
|
Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial.
|
Academic Article
|
Chronic Kidney Disease in Type 2 Diabetes: Optimizing Glucose-Lowering Therapy.
|
Academic Article
|
Evaluating the Effects of Canagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease According to Baseline HbA1c, Including Those With HbA1c <7%: Results From the CREDENCE Trial.
|
Academic Article
|
Microvascular and Cardiovascular Outcomes According to Renal Function in Patients Treated With Once-Weekly Exenatide: Insights From the EXSCEL Trial.
|
Academic Article
|
Clinical and Biomarker Predictors of Expanded Heart Failure Outcomes in Patients With Type 2 Diabetes Mellitus After a Recent Acute Coronary Syndrome: Insights From the EXAMINE Trial.
|
Academic Article
|
Improved Sleep Quality Improves Blood Pressure Control among Patients with Chronic Kidney Disease: A Pilot Study.
|
Academic Article
|
Renal, Cardiovascular, and Safety Outcomes of Canagliflozin by Baseline Kidney Function: A Secondary Analysis of the CREDENCE Randomized Trial.
|
Academic Article
|
Association of Arterial Stiffness With Kidney Function Among Adults Without Chronic Kidney Disease.
|
Academic Article
|
Mineralocorticoid Receptor Antagonists for Hypertension Management in Advanced Chronic Kidney Disease: BLOCK-CKD Trial.
|
Academic Article
|
Multi-proteomic approach to predict specific cardiovascular events in patients with diabetes and myocardial infarction: findings from the EXAMINE trial.
|
Academic Article
|
Timing of randomization after an acute coronary syndrome in patients with type 2 diabetes mellitus.
|
Academic Article
|
Effects of canagliflozin on anaemia in patients with type 2 diabetes and chronic kidney disease: a post-hoc analysis from the CREDENCE trial.
|
Academic Article
|
Finerenone and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Type 2 Diabetes.
|
Academic Article
|
Effects of Canagliflozin in Patients with Baseline eGFR <30 ml/min per 1.73 m2: Subgroup Analysis of the Randomized CREDENCE Trial.
|
Academic Article
|
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes.
|
Academic Article
|
U.S. Prevalence of Individuals With Diabetes and Chronic Kidney Disease Indicated for SGLT-2 Inhibitor Therapy.
|
Academic Article
|
Effects of the Soluble Guanylate Cyclase Stimulator Praliciguat in Diabetic Kidney Disease: A Randomized Placebo-Controlled Clinical Trial.
|
Academic Article
|
Individual Atrasentan Exposure is Associated With Long-term Kidney and Heart Failure Outcomes in Patients With Type 2 Diabetes and Chronic Kidney Disease.
|
Academic Article
|
Effects of canagliflozin on cardiovascular, renal, and safety outcomes in participants with type 2 diabetes and chronic kidney disease according to history of heart failure: Results from the CREDENCE trial.
|
Academic Article
|
Blood Pressure Effects of Canagliflozin and Clinical Outcomes in Type 2 Diabetes and Chronic Kidney Disease: Insights From the CREDENCE Trial.
|
Academic Article
|
Kidney, Cardiovascular, and Safety Outcomes of Canagliflozin according to Baseline Albuminuria: A CREDENCE Secondary Analysis.
|
Academic Article
|
Influence of sex, age and race on coronary and heart failure events in patients with diabetes and post-acute coronary syndrome.
|
Academic Article
|
Effect of KBP-5074 on Blood Pressure in Advanced Chronic Kidney Disease: Results of the BLOCK-CKD Study.
|
Academic Article
|
Finerenone Reduces New-Onset Atrial Fibrillation in Patients With Chronic Kidney Disease and Type 2 Diabetes.
|
Academic Article
|
Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes.
|
Academic Article
|
Body weight changes in patients with type 2 diabetes and a recent acute coronary syndrome: an analysis from the EXAMINE trial.
|
Academic Article
|
Early Response in Albuminuria and Long-Term Kidney Protection during Treatment with an Endothelin Receptor Antagonist: A Prespecified Analysis from the SONAR Trial.
|
Academic Article
|
Untreated Hypertension and Subsequent Incidence of Colorectal Cancer: Analysis of a Nationwide Epidemiological Database.
|
Academic Article
|
Hyperkalemia Risk with Finerenone: Results from the FIDELIO-DKD Trial.
|
Academic Article
|
Finerenone Reduces Risk of Incident Heart Failure in Patients With Chronic Kidney Disease and Type 2 Diabetes: Analyses From the FIGARO-DKD Trial.
|
Academic Article
|
Blood and Urine Biomarkers Predicting Worsening Kidney Function in Patients with Type 2 Diabetes Post-Acute Coronary Syndrome: An Analysis from the EXAMINE Trial.
|
Academic Article
|
Effect of the Glucagon-Like Peptide-1 Receptor Agonists Semaglutide and Liraglutide on Kidney Outcomes in Patients With Type 2 Diabetes: Pooled Analysis of SUSTAIN 6 and LEADER.
|
Academic Article
|
Potential Role and Limitations of Estimated Glomerular Filtration Rate Slope Assessment in Cardiovascular Trials: A Review.
|
Academic Article
|
Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study.
|
Academic Article
|
Novel Renal Autologous Cell Therapy for Type 2 Diabetes Mellitus Chronic Diabetic Kidney Disease: Clinical Trial Design.
|
Academic Article
|
Potential Effects of Elimination of the Black Race Coefficient in eGFR Calculations in the CREDENCE Trial.
|
Academic Article
|
Treatment of Resistant Hypertension With Endovascular Baroreflex Amplification: 3-Year Results From the CALM-FIM Study.
|
Academic Article
|
Mineralocorticoid Receptor Antagonists in the Treatment of Diabetic Kidney Disease: Their Application in the Era of SGLT2 Inhibitors and GLP-1 Receptor Agonists.
|
Academic Article
|
Cardiovascular Effects of Canagliflozin in Relation to Renal Function and Albuminuria.
|
Academic Article
|
Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial.
|
Academic Article
|
Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex: A Post Hoc Analysis of the CREDENCE Randomized Clinical Trial.
|
Academic Article
|
The sodium-glucose cotransporter-2 inhibitor canagliflozin does not increase risk of non-genital skin and soft tissue infections in people with type 2 diabetes mellitus: A pooled post hoc analysis from the CANVAS Program and CREDENCE randomized double-blind trials.
|
Academic Article
|
Modifiability of Composite Cardiovascular Risk Associated With Chronic Kidney Disease in Type 2 Diabetes With Finerenone.
|
Academic Article
|
Association of uncontrolled blood pressure in apparent treatment-resistant hypertension with increased risk of major adverse cardiovascular events plus.
|
Academic Article
|
Efficacy of finerenone in patients with type 2 diabetes, chronic kidney disease and altered markers of liver steatosis and fibrosis: A FIDELITY subgroup analysis.
|
Academic Article
|
RNA Interference With Zilebesiran for Mild to Moderate Hypertension: The KARDIA-1 Randomized Clinical Trial.
|
Academic Article
|
Finerenone cardiovascular and kidney outcomes by age and sex: FIDELITY post hoc analysis of two phase 3, multicentre, double-blind trials.
|